III-174 (Johns Hopkins)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIII-174 (Johns Hopkins)
Drug Alias Nameanti-HSV (Johns Hopkins)III-174
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsHerpes Simplex Virus Type 2 Infections

Other Information

ATC CodeN/A
Related LinksN/A